Search research articles
Contact Us
Filters
Showing results (71-80 of 87) with videos related to
Page
of 9
Sort By:
Pediatrics
|
September 1, 1989
Substance use among eighth-grade students who take care of themselves after school
J L Richardson, K Dwyer, K McGuigan, et al.
Preventive Medicine
|
January 1, 1995
The television, school, and family smoking prevention and cessation project. VIII. Student outcomes and mediating variables
B R Flay, T Q Miller, D Hedeker, et al.
FEBS Letters
|
May 18, 2010
Direct visualization of the small hydrophobic protein of human respiratory syncytial virus reveals the structural basis for membrane permeability
Stephen D Carter, Kyle C Dent, Elizabeth Atkins, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 21, 2006
The identification of pyrimidine-diazabicyclo[3.3.0]octane derivatives as 5-HT2C receptor agonists
Bayard R Huck, Luis Llamas, Michael J Robarge, et al.
International Review of Cytology
|
January 1, 1992
Sugar-cation symport systems in bacteria
P J Henderson, S A Baldwin, M T Cairns, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 6, 2006
The design and synthesis of a tricyclic single-nitrogen scaffold that serves as a 5-HT2C receptor agonist
Bayard R Huck, Luis Llamas, Michael J Robarge, et al.
Applied Microbiology and Biotechnology
|
July 8, 2010
Structural and biochemical characterization of a nitrilase from the thermophilic bacterium, Geobacillus pallidus RAPc8
Dael S Williamson, Kyle C Dent, Brandon W Weber, et al.
Journal of Gastroenterology and Hepatology
|
October 16, 2004
Four years of lamivudine treatment in Chinese patients with chronic hepatitis B
Ting-Tsung Chang, Ching-Lung Lai, Rong-Nan Chien, et al.
Hepatology (Baltimore, Md.)
|
June 8, 2001
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy
N W Leung, C L Lai, T T Chang, et al.
The New England Journal of Medicine
|
July 9, 1998
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group
C L Lai, R N Chien, N W Leung, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 87) with videos related to
Sort By:
Page
of 9
Pediatrics
|
September 1, 1989
Substance use among eighth-grade students who take care of themselves after school
J L Richardson, K Dwyer, K McGuigan, et al.
Preventive Medicine
|
January 1, 1995
The television, school, and family smoking prevention and cessation project. VIII. Student outcomes and mediating variables
B R Flay, T Q Miller, D Hedeker, et al.
FEBS Letters
|
May 18, 2010
Direct visualization of the small hydrophobic protein of human respiratory syncytial virus reveals the structural basis for membrane permeability
Stephen D Carter, Kyle C Dent, Elizabeth Atkins, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 21, 2006
The identification of pyrimidine-diazabicyclo[3.3.0]octane derivatives as 5-HT2C receptor agonists
Bayard R Huck, Luis Llamas, Michael J Robarge, et al.
International Review of Cytology
|
January 1, 1992
Sugar-cation symport systems in bacteria
P J Henderson, S A Baldwin, M T Cairns, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 6, 2006
The design and synthesis of a tricyclic single-nitrogen scaffold that serves as a 5-HT2C receptor agonist
Bayard R Huck, Luis Llamas, Michael J Robarge, et al.
Applied Microbiology and Biotechnology
|
July 8, 2010
Structural and biochemical characterization of a nitrilase from the thermophilic bacterium, Geobacillus pallidus RAPc8
Dael S Williamson, Kyle C Dent, Brandon W Weber, et al.
Journal of Gastroenterology and Hepatology
|
October 16, 2004
Four years of lamivudine treatment in Chinese patients with chronic hepatitis B
Ting-Tsung Chang, Ching-Lung Lai, Rong-Nan Chien, et al.
Hepatology (Baltimore, Md.)
|
June 8, 2001
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy
N W Leung, C L Lai, T T Chang, et al.
The New England Journal of Medicine
|
July 9, 1998
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group
C L Lai, R N Chien, N W Leung, et al.
Page
of 9